Next-generation sequencing (NGS) provides tremendous benefits for molecular testing of myeloid malignancies. With an ever-growing list of biomarkers, inherent genetic complexity, and the risk of rapid progression, myeloid malignancies challenge the current iterative testing paradigm and call for a streamlined testing approach that yields rapid results. Read our interactive ebook to:
- Understand how NGS is transforming molecular testing for myeloid malignancies
- Learn the fundamentals of NGS testing
- See how NGS testing can provide deep insight across the care continuum—from initial diagnosis to monitoring applications
Please fill out this brief form to view the interactive ebook. If you would like a representative to contact you to discuss NGS testing for your lab, you can select that option below.